Clinical evidence highlight significant cost savings when using LiDCO
Several studies have suggested that perioperative hemodynamic optimization is cost-effective (Bartha et al. Anesthesiology 2012, Ebm et al. Crit Care Med 2014, Manecke et al. Crit Care 2014).
However, all these studies are modelizations or projections based on cost estimations and assumptions. They are not prospective demonstrations that the savings associated with the reduction in postoperative complications overcome the costs associated with monitoring equipment and implementation.
In a randomized controlled trial (Pearse et al. JAMA 2014) done in >700 patients undergoing major abdominal surgery, hemodynamic optimization with the LiDCO minimally invasive monitor led to a 16% (before adjustment) or 20% (after adjustment for non-compliance) reduction in postoperative morbidity.
As a result, and because postoperative complications are expensive to treat, patients monitored with the LiDCO minimally invasive monitor were on average $530 less expensive to treat than control patients who were not monitored (Sadique et al. Perioper Med 2015) (Figure 3). Simply stated, hemodynamic optimization with the LiDCO system has been shown to be useful to improve quality of surgical care and decrease hospital costs at the same time.
Figure 1 (above): In a large randomized controlled trial (>700 patients undergoing major abdominal surgery), perioperative hemodynamic optimization with the LiDCO minimally invasive monitor was associated with a reduction in hospital cost/patient (adapted from Sadique et al. Perioper Med 2015)